SCHEMBL4459861

SCHEMBL4459861

COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2cccc(C(NC(=O)C3CNC3)c3ccccc3)c2)cc(OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 8/20 0.53
PIK3CD O00329 5/20 0.53
PIK3CA P42336 4/20 0.53
PIK3CB P42338 3/20 0.53
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
PRKDC P78527 2/20 0.47
MTOR P42345 1/20 0.47
RPTOR Q8N122 1/20 0.47
MLST8 Q9BVC4 1/20 0.47
MAPT P10636 4/20 0.45
PIK3C2B O00750 1/20 0.43
PIK3C2G O75747 1/20 0.43
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
GFER P55789 1/20 0.42
KDM4E B2RXH2 1/20 0.42
TNF P01375 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4344198 0.91 PIK3CD (0.49) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL4343998 0.89 PIK3CG (0.51) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL4540214 0.87 PIK3CG (0.52) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL189191 0.85 PIK3CG (0.58) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL3143741 0.83 PIK3CD (0.56) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL3803471 0.82 PIK3CD (0.57) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL12373147 0.81 PIK3CG (0.52) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL18324098 0.81 PIK3CG (0.52) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL2280427 0.80 PIK3CD (0.53) PIK3CGPIK3CDPIK3CAPIK3CBMEN1
SCHEMBL4457141 0.79 PIK3CG (0.61) PIK3CGPIK3CDPIK3CAPIK3CBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO claimed